kabutan

SAWAI GROUP HOLDINGS Co.,Ltd.(4887) Summary

4887
TSE Prime
SAWAI GROUP HOLDINGS Co.,Ltd.
2,139.5
JPY
+72.5
(+3.51%)
Dec 5, 12:48 pm JST
13.79
USD
Dec 4, 10:48 pm EST
Result
PTS
outside of trading hours
2,143.4
Dec 5, 12:47 pm JST
Summary Chart Historical News Financial Result
PER
17.6
PBR
1.40
Yield
2.57%
Margin Trading Ratio
1.39
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
2,095.0 JPY 13.50 USD
Previous Close Dec 4
2,067.0 JPY 13.30 USD
High Dec 5, 9:28 am
2,217.5 JPY 14.29 USD
Low Dec 5, 9:00 am
2,094.5 JPY 13.50 USD
Volume
555,600
Trading Value
1.21B JPY 7.77M USD
VWAP
2168.73 JPY 13.98 USD
Minimum Trading Value
213,950 JPY 1,379 USD
Market Cap
0.25T JPY 1.59B USD
Number of Trades
2,774
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
High
1-Year Average
1,735
1-Year High Feb 14, 2025
5,946
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 82,900 43,500 0.52
Nov 21, 2025 83,200 61,400 0.74
Nov 14, 2025 87,900 79,200 0.90
Nov 7, 2025 65,000 72,800 1.12
Oct 31, 2025 83,000 86,200 1.04
Company Profile
SAWAI GROUP HOLDINGS Co., Ltd. is a leading generic pharmaceutical company, specializing in lifestyle disease treatments and anti-cancer drugs. The company is focusing on expanding its business in the United States.
Sector
Pharmaceuticals
SAWAI GROUP HOLDINGS Co., Ltd. primarily engages in the manufacturing and sales of prescription and over-the-counter pharmaceuticals. The group consists of a holding company and eight consolidated subsidiaries, operating under a single segment of "manufacturing and sales of pharmaceuticals and related products." The core company, Sawai Pharmaceutical Co., Ltd., manufactures and sells pharmaceuticals to domestic distributors, wholesalers, other pharmaceutical manufacturers, and medical institutions. Medisa Shinyaku Co., Ltd. handles the sales of prescription drugs, while Kaken Shoyaku Co., Ltd. is responsible for the manufacturing and sales of prescription drugs and the supply of primary raw materials. Trust Pharmatech Co., Ltd. manufactures and sells prescription drugs and is entrusted with part of the research and development and manufacturing operations from Sawai Pharmaceutical. The group as a whole strives for efficient business operations and aims to strengthen its competitiveness in the pharmaceutical market.